Immunosuppression contributes significantly to the caseload of visceral leishmaniasis (VL).
HIV coinfection, solid organ transplantation, malnutrition, and helminth infections are the …

Leishmaniasis significantly affects the population of the tropics and subtropics. Clinical
features and infective species of Leishmania are the primary factors driving the direction of …

Visceral leishmaniasis (VL) is a rare disease in solid-organ transplant (SOT) recipients.
Therefore, little is known about the risk factors and disease behavior in the transplant setting …

Visceral leishmaniasis is an uncommon disease in transplant recipients; however, if left
untreated, the mortality can be high. If an organ donor or recipient is known to be an …

Current knowledge on Leishmania infection after kidney transplantation (KT) is limited. In
order to offer a comprehensive guide for the management of post-transplant Leishmaniasis …

Visceral leishmaniasis (VL) is a parasitic disease, caused by protozoa of the genus
Leishmania, transmitted by the phlebotomies sand fly. In the last 20 years, the increasing …

Özet Amaç: Bu çalışmada ülkemizden bildirilmiş erişkin viseral layşmanyaz olguları havuz
analiziyle değerlendirilerek hastalığın ülkemizde görüldüğüne vurgu yapılması, klinik ve …

Leishmaniasis is an infection caused by protozoa of the genus Leishmania, transmitted by
sandflies and endemic to more than 88 countries. Visceral leishmaniasis in …

Leishmaniasis is a disease caused by a protozoan and transmitted by sandfly species in
several emerging countries. Visceral leishmaniasis is a serious complication, especially in …

Leishmaniasis is a rare disease in both solid-organ and hematopoietic stem cell
transplantation. Additionally, the frequency of disease is likely related to the leishmaniasis …